ArticleCancers2026

COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma.

Michael Weichenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.